Oncology Institute Correlations

TOI Stock

USD 3.50 0.15 4.11%

The correlation of Oncology Institute is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Oncology Institute Correlation With Market

Average diversification

The correlation between Oncology Institute and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Oncology Institute and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Oncology Stock

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.

Moving against Oncology Stock

0.37	CI	Cigna Corp	Pair Corr
0.36	VERO	Venus Concept	Pair Corr
0.31	GH	Guardant Health	Pair Corr
0.31	VTAK	Catheter Precision	Pair Corr
0.6	CVS	CVS Health Corp	Pair Corr
0.47	MSPRZ	MSP Recovery Symbol Change	Pair Corr
0.41	ELMD	Electromed	Pair Corr

Related Correlations Analysis

	PIII	SNDA	ACHC	CCEL	TNGX
PIII		-0.53	0.32	0.28	-0.88	PIII
SNDA	-0.53		0.41	-0.64	0.38	SNDA
ACHC	0.32	0.41		-0.28	-0.3	ACHC
CCEL	0.28	-0.64	-0.28		-0.16	CCEL
TNGX	-0.88	0.38	-0.3	-0.16		TNGX
	PIII	SNDA	ACHC	CCEL	TNGX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ACHC	+ 0.41	SNDA
TNGX	+ 0.38	SNDA
ACHC	+ 0.32	PIII
CCEL	+ 0.28	PIII

High negative correlations

TNGX	- 0.88	PIII
CCEL	- 0.64	SNDA
SNDA	- 0.53	PIII
TNGX	- 0.3	ACHC
CCEL	- 0.28	ACHC
TNGX	- 0.16	CCEL

Risk-Adjusted Indicators

There is a big difference between Oncology Stock performing well and Oncology Institute Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oncology Institute's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PIII	2.29	(0.49)	0.00	(1.00)	0.00	0.00	5.20	(4.87)	15.07
SNDA	1.64	(0.03)	0.04	0.12	1.62	(1.89)	3.70	(3.06)	13.23
ACHC	2.55	(0.48)	0.00	(0.13)	0.00	0.00	4.62	(4.53)	15.10
CCEL	2.05	(0.17)	0.00	(0.66)	0.00	0.00	5.59	(4.60)	16.27
TNGX	6.54	2.44	0.47	0.84	4.42	(8.15)	20.10	(8.72)	62.27

Oncology Institute Corporate Management

FACHE MD	Chief Officer	Profile
Mark Esq	General Counsel	Profile
Robert Carter	Chief Officer	Profile
Rob Carter	Senior Finance	Profile
Stephen Cella	Senior Finance	Profile
Bradford Hively	CEO Director	Profile
Rakesh MBA	Director Technology	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC